絞り込み

16636

広告

「"Wei AH"[Author]」の検索結果

58件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Clinicopathological aspects of therapy-related acute myeloid leukemia and myelodysplastic syndrome.

Genomic subtyping and therapeutic targeting of acute erythroleukemia.

Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study.

New drugs creating new challenges in acute myeloid leukemia.

BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines.

HPLC analysis, optimization of extraction and purification conditions, biological evaluation of total protoflavones from Macrothelypteris viridifrons.

Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia.

Combining BH3-Mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia.

Increased risk of myocardial infarction with dabigatran etexilate: fact or fiction? A critical meta-analysis of over 580,000 patients from integrating randomized controlled trials and real-world studies.

Identifying Genetic Players in Cell Sheet Morphogenesis Using a Deficiency Screen for Genes on Chromosome 2R Involved in Dorsal Closure.

[Study on original investigation, macroscopic and microscopic identification of pharmacopoeia contained species of Epmedii Folium].

The safety of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension: Protocol for a systemic review and network meta-analysis.

Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.

Midostaurin, enasidenib, CPX-351, gemtuzumab ozogomycin and venetoclax bring new hope to AML.

Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1.

Corrigendum to "KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study" [Leuk. Res. 50 (Nov) (2016) 123-131. PubMed PMID: 27736729].

  1. 1
  2. 2
  3. 3
Sort by
※並べ替えは表示に時間がかかります